Cite
HARVARD Citation
Mu, P. (n.d.). CHD-loss promotes tumor heterogeneity, lineage plasticity and resistance to AR targeted therapy resistance. European journal of cancer. pp. S22-S23. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mu, P. (n.d.). CHD-loss promotes tumor heterogeneity, lineage plasticity and resistance to AR targeted therapy resistance. European journal of cancer. pp. S22-S23. [Online].